Literature DB >> 25413086

ERKquake in Noonan syndrome: one step closer to personalized medicine.

Mauro Costa-Mattioli1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25413086     DOI： 10.1038/nn.3879

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN： 1097-6256            Impact factor:   24.884


× No keyword cloud information.
  15 in total

Review 1.  The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.

Authors:  Benjamin G Neel; Haihua Gu; Lily Pao
Journal:  Trends Biochem Sci       Date:  2003-06       Impact factor: 13.807

Review 2.  Small G protein signaling in neuronal plasticity and memory formation: the specific role of ras family proteins.

Authors:  Xiaojing Ye; Thomas J Carew
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

3.  The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1.

Authors:  Weidong Li; Yijun Cui; Steven A Kushner; Robert A M Brown; J David Jentsch; Paul W Frankland; Tyrone D Cannon; Alcino J Silva
Journal:  Curr Biol       Date:  2005-11-08       Impact factor: 10.834

4.  Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1.

Authors:  Rui M Costa; Nikolai B Federov; Jeff H Kogan; Geoffrey G Murphy; Joel Stern; Masuo Ohno; Raju Kucherlapati; Tyler Jacks; Alcino J Silva
Journal:  Nature       Date:  2002-01-16       Impact factor: 49.962

Review 5.  Noonan syndrome and related disorders: genetics and pathogenesis.

Authors:  Marco Tartaglia; Bruce D Gelb
Journal:  Annu Rev Genomics Hum Genet       Date:  2005       Impact factor: 8.929

6.  Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path.

Authors:  T V Bliss; T Lomo
Journal:  J Physiol       Date:  1973-07       Impact factor: 5.182

Review 7.  Translational control in synaptic plasticity and cognitive dysfunction.

Authors:  Shelly A Buffington; Wei Huang; Mauro Costa-Mattioli
Journal:  Annu Rev Neurosci       Date:  2014       Impact factor: 12.449

8.  Cognitive profile of disorders associated with dysregulation of the RAS/MAPK signaling cascade.

Authors:  Laura Cesarini; Paolo Alfieri; Francesca Pantaleoni; Isabella Vasta; Marta Cerutti; Valentina Petrangeli; Paolo Mariotti; Chiara Leoni; Daniela Ricci; Stefano Vicari; Angelo Selicorni; Marco Tartaglia; Eugenio Mercuri; Giuseppe Zampino
Journal:  Am J Med Genet A       Date:  2009-02       Impact factor: 2.802

Review 9.  The medial temporal lobe.

Authors:  Larry R Squire; Craig E L Stark; Robert E Clark
Journal:  Annu Rev Neurosci       Date:  2004       Impact factor: 12.449

Review 10.  Noonan syndrome.

Authors:  Amy E Roberts; Judith E Allanson; Marco Tartaglia; Bruce D Gelb
Journal:  Lancet       Date:  2013-01-10       Impact factor: 79.321
View more
  2 in total

Review 1.  RASopathies: unraveling mechanisms with animal models.

Authors:  Granton A Jindal; Yogesh Goyal; Rebecca D Burdine; Katherine A Rauen; Stanislav Y Shvartsman
Journal:  Dis Model Mech       Date:  2015-08-01       Impact factor: 5.758

2.  Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1.

Authors:  Elizabeth I Pierpont; Rebekah L Hudock; Allison M Foy; Margaret Semrud-Clikeman; Mary Ella Pierpont; Susan A Berry; Ryan Shanley; Nathan Rubin; Katherine Sommer; Christopher L Moertel
Journal:  J Neurodev Disord       Date:  2018-06-18       Impact factor: 4.025
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.